Kitakata, H.; Kohsaka, S.; Kuroda, S.; Nomura, A.; Kitai, T.; Yonetsu, T.; Torii, S.; Matsue, Y.; Matsumoto, S.
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. J. Clin. Med. 2021, 10, 3086.
https://doi.org/10.3390/jcm10143086
AMA Style
Kitakata H, Kohsaka S, Kuroda S, Nomura A, Kitai T, Yonetsu T, Torii S, Matsue Y, Matsumoto S.
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. Journal of Clinical Medicine. 2021; 10(14):3086.
https://doi.org/10.3390/jcm10143086
Chicago/Turabian Style
Kitakata, Hiroki, Shun Kohsaka, Shunsuke Kuroda, Akihiro Nomura, Takeshi Kitai, Taishi Yonetsu, Sho Torii, Yuya Matsue, and Shingo Matsumoto.
2021. "Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients" Journal of Clinical Medicine 10, no. 14: 3086.
https://doi.org/10.3390/jcm10143086
APA Style
Kitakata, H., Kohsaka, S., Kuroda, S., Nomura, A., Kitai, T., Yonetsu, T., Torii, S., Matsue, Y., & Matsumoto, S.
(2021). Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. Journal of Clinical Medicine, 10(14), 3086.
https://doi.org/10.3390/jcm10143086